Tokyo, Japan and Cambridge, UK, 28 August 2024 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) – formerly known as Sosei Group or Sosei Heptares – notes the announcement by its partner ...
Tokyo, Japan and Cambridge, UK, 29 May 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) notes that Neurocrine Biosciences, Inc. announced that it had presented new positive data from ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Ligand Pharma ( (LGND)) has shared an ...
The COVID-19 pandemic has millennials worried—and that has them planning to buy more prescription drugs in the future, new research finds. WPP's global media group, Mindshare, began surveying ...
NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) announced today that it has priced an offering of $2.0 billion of senior unsecured notes, comprised of the following ...
• Abbott, of Abbott Park, Ill., has pleaded guilty and agreed to pay $1.5 billion as part of a settlement with U.S. federal and state authorities to resolve issues related to the big pharma's ...
Hosted on MSN
Alnylam Pharma Executes Note Repurchase Transactions
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Alnylam Pharma ( (ALNY)) has provided an ...
NEW YORK, April 16, 2021 /PRNewswire/ — AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today noted that a recent study announced positive early results from a PSMA 617-Lu177 study ...
$600 million of 4.450% Notes due 2031 (the “2031 Notes”); $900 million of 5.200% Notes due 2035 (the “2035 Notes”); and $500 million of 5.950% Notes due 2055 (the “2055 Notes”). The Notes will be ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback